Vaccination

Left-behind Sanofi closes in on Covid vaccine

French pharmaceuticals giant Sanofi on Monday reported positive results in trials of its belated Covid-19 jab, raising hopes that France can finally make up lost ground after falling behind in the race to develop a vaccine.

Diseases, Conditions, Syndromes

Jab-free dengue immunity could be just a click away

A dengue virus vaccine candidate has passed an important milestone, with promising results in animal model testing providing hope to the 390 million people infected every year.

Vaccination

Novavax delays Covid vaccine authorization request

US biotech firm Novavax on Monday said it had delayed plans to seek authorization for its Covid vaccine candidate, a setback for developing countries hoping the injection would soon be available.

Diseases, Conditions, Syndromes

Malaria vaccine 'first to meet WHO efficacy target'

A malaria vaccine candidate tested on children in West Africa has shown an efficacy of around 77 percent, say scientists, hailing it as a breakthrough in the fight against the disease.

Pediatrics

Novavax starts COVID-19 vaccine trials on children

US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.

page 2 from 36